We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Nativis entered into a license agreement in 2017 for the development of the technology for the treatment of adults with glioblastoma multiforme in the Japanese market. Read More